QMS Medical Allied Services Limited

QMS Medical Allied Services Limited

NNSE:QMSMEDI
171.03
INR
-4.36
(-2.49%)
6.52EPS
16.63P/E
1.97BMarket Cap
QMS Medical Allied Services Limited
NSE:QMSMEDI
(National Stock Exchange of India)

Recent

price

171.03

P/E

ratio

16.63

div

yld

- -

ROIC.AI

2020
2021
2022
2023
2024
2025
2026
TTM
INR
40.29
67.59
81.04
62.84
67.6
85.85
92.06
93.89
Revenue per Share
3.52
6.05
5.92
3.85
4.98
6.65
5.4
6.13
Basic EPS, GAAP
-1.32
1.04
-2.11
-5.57
-0.66
8.66
7.27
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
0.49
0.49
0.48
- -
Dividend per Share
5.21
11.26
17.19
38.99
43.49
49.69
53.88
- -
Book Value per Share
5.15
11.17
17.18
38.18
42.18
31.64
36.01
- -
Tangible Book Value per Share
18
18
18
17
18
18
19
20
Basic Weighted Avg Shares
727
1,220
1,463
1,040
1,221
1,560
1,729
1,832
Sales/Revenue/Turnover
12.72
13.34
10.57
9.92
12.21
13.94
12.89
12.66
Operating Margin (%)
4
7
12
11
34
38
39
45
Depreciation Expense
64
109
107
64
90
121
101
120
Net Income, GAAP
27.15
26.76
26.08
26.68
26.43
26.6
27.51
27.34
Effective Tax Rate (%)
8.73
8.95
7.3
6.13
7.37
7.75
5.86
6.52
Profit Margin (%)
60
108
249
415
518
469
507
- -
Working Capital
- -
11
20
15
24
94
70
- -
LT Debt
94
203
310
704
785
1,071
1,140
- -
Total Equity
- -
38.96
23.77
9.33
10.37
11.28
9.03
- -
Return on Invested Capital (%)
- -
38.81
23.81
9.87
10.82
9.84
7.09
- -
Return on Capital (%)
- -
73.45
41.62
12.58
12.09
14.38
10.45
- -
Return on Common Equity (%)

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
675
- -
LT Borrowings
- -
70
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
19
19
19
Market Capitalization
- -
- -
1,970

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
1,420
- -
Cash, Cash Equivalents & STI
- -
67
- -
Accounts Receivable, Net
- -
436
- -
Inventories
- -
459
- -
Total Current Liabilities
- -
913
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
675
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
46.78%
6.41%
Free Cash Flow
- -
-335.52%
-13.22%
Net Income, GAAP
- -
3.36%
-16.21%
Sales/Revenue/Turnover
- -
9.39%
10.81%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
304
372
439
446
1,560
2026
465
447
373
444
1,729
2027
569
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
1.32
1.89
1.6
1.84
6.65
2026
2.2
1.71
1.64
0.89
5.4
2027
2.05
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
0.49
2026
- -
- -
- -
- -
0.48
2027
- -
- -
- -
- -
- -
Business
QMS Medical Allied Services Ltd. (NSE: QMSMEDI.NS) operates as a healthcare services provider in India, offering a range of medical allied solutions including home healthcare, patient transportation, medical equipment rental, and diagnostic services. The company delivers comprehensive patient care through services such as nursing, physiotherapy, ambulance operations, oxygen therapy, and hospital-at-home programs; it also provides specialized equipment like wheelchairs, hospital beds, and ventilators on rent, alongside diagnostic tests including pathology and imaging. Headquartered in Mumbai, India, and founded in 2023, QMS Medical Allied Services primarily targets urban and semi-urban markets in Maharashtra and expanding regions across India, serving individual patients, hospitals, and corporate clients in the post-acute care segment. In recent developments, the company secured a significant funding round in early 2025 from institutional investors to fuel expansion into tier-2 cities and enhance its digital booking platform for services. It launched a new fleet of advanced ambulances equipped with telemedicine capabilities in mid-2025, partnering with leading hospitals in Mumbai and Pune for seamless patient transfers and remote consultations. Additionally, QMS Medical Allied Services announced a strategic alliance with a major pharmaceutical distributor in late 2024 to integrate medicine delivery with its home care offerings, marking a shift toward integrated healthcare ecosystems. These initiatives reflect the company's aggressive growth strategy amid rising demand for accessible medical allied services in India's healthcare landscape.